Written Question·Department of Health and Social Care·UIN 428
Polycystic Ovary Syndrome: Semaglutide
Tabled: 17 July 2024
Answered: 29 July 2024
Question
Jess Asato
Labour — Lowestoft
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of prescribing semiglutides on the NHS for patients with polycystic ovary syndrome.
Answer
Karin SmythWhile semaglutide is not licensed as a treatment option for polycystic ovary syndrome (PCOS), clinicians can prescribe medicines outside their licensed indication, known as off-label prescribing, where they consider it to be the best treatment option for ...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 428) →